Clinical Trial Update: Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)
• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Matthew Galsky | Conditions: Metastatic Urothelial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-05-16